NFE2L2 and melanoma: In addition to BRAFi-resistant melanoma, the role of Nrf2 was shown in melanoma cells, which also mediates temozolomide (TMZ) resistance in melanoma cells, an DNA alkylating agent, by upregulation of GSH synthesis.